URGN
UroGen Pharma Ltd

2,320
Mkt Cap
$1.18B
Volume
723,210.00
52W High
$25.60
52W Low
$3.42
PE Ratio
-7.30
URGN Fundamentals
Price
$24.84
Prev Close
$25.27
Open
$25.78
50D MA
$19.37
Beta
1.05
Avg. Volume
977,695.70
EPS (Annual)
-$2.96
P/B
-10.24
Rev/Employee
$384,672.34
Loading...
Loading...
News
all
press releases
Urogen Pharma (NASDAQ:URGN) Shares Up 7.3% - Still a Buy?
Urogen Pharma (NASDAQ:URGN) Shares Up 7.3% - Time to Buy...
MarketBeat·1h ago
News Placeholder
More News
News Placeholder
Persistent Asset Partners Ltd Buys 17,029 Shares of Urogen Pharma $URGN
Persistent Asset Partners Ltd lifted its stake in Urogen Pharma (NASDAQ:URGN - Free Report) by 96.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange...
MarketBeat·3d ago
News Placeholder
Urogen Pharma $URGN Shares Bought by SG Americas Securities LLC
SG Americas Securities LLC increased its holdings in Urogen Pharma (NASDAQ:URGN - Free Report) by 607.1% during the second quarter, according to its most recent filing with the Securities and...
MarketBeat·3d ago
News Placeholder
Los Angeles Capital Management LLC Invests $445,000 in Urogen Pharma $URGN
Los Angeles Capital Management LLC acquired a new stake in Urogen Pharma (NASDAQ:URGN - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional...
MarketBeat·3d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Sets New 12-Month High - Here's Why
Urogen Pharma (NASDAQ:URGN) Hits New 1-Year High - Here's What Happened...
MarketBeat·7d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Upgraded to "Hold" at Wall Street Zen
Wall Street Zen upgraded shares of Urogen Pharma from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·13d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Announces Earnings Results
Urogen Pharma (NASDAQ:URGN - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.69) earnings per share (EPS) for the quarter, topping analysts' consensus...
MarketBeat·13d ago
News Placeholder
Urogen Pharma (NASDAQ:URGN) Sets New 1-Year High After Strong Earnings
Urogen Pharma (NASDAQ:URGN) Reaches New 52-Week High After Better-Than-Expected Earnings...
MarketBeat·13d ago
News Placeholder
Urogen Pharma (URGN) Reports Q3 Loss, Misses Revenue Estimates
Urogen Pharma (URGN) delivered earnings and revenue surprises of +4.17% and -11.29%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Adherex Technologies Inc. (FENC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Adherex Technologies (FENC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·21d ago

Latest URGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.